# Oxygenta Pharmaceutical Ltd (OXYGENTAPH)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹55.54
Day Change: -3.98%
52W High: ₹133.5
52W Low: ₹45.3
Market Cap: ₹205 Cr

## Valuation
P/E: 0
P/B: -5.61
EPS: ₹-4.72
Book Value: ₹0
Dividend Yield: 0%

## Returns
1Y Return: -34.67%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Oxygenta Pharmaceutical Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Oxygenta Pharmaceutical Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- BSE Filing: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-16T23:57:05.006Z
Price History Updated: 2026-05-18T22:59:38.191Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-18T22:59:38.191Z
Quant Updated: 2026-05-18T22:59:38.191Z
Sentiment Updated: 2026-05-18T22:59:38.191Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:01.148Z
Financials Last Attempt: 2026-05-18T12:30:01.148Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2022)
Revenue: ₹61 Cr
Operating Profit: ₹0 Cr (OPM -0.19%)
Net Profit: ₹-1 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2022: Rev ₹61Cr | PAT ₹-1Cr | OPM -0.19%
FY 2023: Rev ₹31Cr | PAT ₹-12Cr | OPM -29.52%
FY 2024: Rev ₹40Cr | PAT ₹-3Cr | OPM -31.14%

## Balance Sheet (FY 2022)
Total Assets: ₹31 Cr
Total Liabilities: ₹66 Cr
Borrowings: ₹52 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/oxygentaph
Disclaimer: For research and education only. Not investment advice.